# Mission and Market

> Mission and Market is a VC fund backing Health Care and Biotechnology. See 37 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: San Francisco, United States
- Total investments: 37
- Last investment: Aug 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/mission-and-market/about/
- X (Twitter): https://twitter.com/missionmarketvc
- Website: http://m14t.com/

Mission and Market is a micro-venture capital firm focused on seed investments in many areas, including big data, software-powered biotech.

## Contacts

5 contacts available for Mission and Market. Shizune tracks 2 team members at Mission and Market. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/mission-and-market?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1M–$5M |
| Series A | $10M–$17M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 24% |
| Biotechnology | 6 | 16% |
| Machine Learning | 6 | 16% |
| Financial Services | 6 | 16% |
| Software | 5 | 14% |

92 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 26 | 70% |
| Series A | 5 | 14% |
| Funding Round | 3 | 8% |
| Venture - Series Unknown | 2 | 5% |
| Series B | 1 | 3% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 32 | 86% |
| Japan | 1 | 3% |
| Israel | 1 | 3% |
| Sweden | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Francesco Simoneschi | Co-Founder and Partner | 7 | https://shizune.co/investors/profile/francesco-simoneschi |
| Simone Brunozzi | Founder, General Manager | 3 | https://shizune.co/investors/profile/simone-brunozzi |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cofactor Genomics | Cofactor Genomics is a company focused on predictive immune modeling. They aim to advance precision medicine by overcoming existing barriers. Cofactor facilitates the shift from single-analyte biomarkers to more comprehensive multidimensional biomarkers using health expression models. Their capabilities include molecular, informatic, and databasetools, with one of the first CAP-certified clinical RNA sequencing laboratories. This certification helps their partners conduct clinical trials more efficiently and cost-effectively. Their expertise in molecular biology, informatics, and database management enables them to provide high-quality services to the healthcare and pharmaceutical sectors, contributing to medical research and improving patient outcomes. | $1.2M | Venture - Series Unknown | Aug 02, 2023 |  |
| Fove | FOVE offers an eye tracking head mount display. Dive into virtual worlds that know where you are looking, what you are looking at and react to it. Think Iron Man meets Oculus. By tracking gaze position in real time it is possible to interact with and control objects on the screen in new ways. | $4M | Venture - Series Unknown | Jan 03, 2022 |  |
| Akido Labs | Akido is a care delivery platform focused on overcoming the complex needs of our most vulnerable populations. We are on a mission to leverage modern technology and proprietary datasets that have historically been locked up in our public health ecosystems in order to radically improve the quality of life and affordability of care for underservedpeople.We are a fast-growing, impact-focused, Y Combinator company being used nationwide to combat the Covid-19 pandemic, homelessness, and other public health crises. Across the country, health systems and government service providers use Akido to launch new technology-powered public health initiatives that improve the health and well-being of the communities they serve. | $11.2M | Series A | Dec 16, 2021 |  |
| Cymmetria | Cymmetria is a cybersecurity company at the forefront of deception technology. Cymmetria’s deception products, MazeRunner and ActiveSOC, give organizations the ability to hunt attackers, detect lateral movement inside the perimeter, automate incident response, and mitigate attacks. The company also offers deception as a service, enablingorganizations to customize deception technologies for their business environment. Founded in 2014 by security expert Gadi Evron, Cymmetria is changing the asymmetry of cybersecurity, giving defenders the upper hand. |  |  | Aug 27, 2018 |  |
| Replit | Replit provides a cloud-based software development platform that allows users to write, run, and deploy applications through a browser-based environment. The platform includes an integrated code editor, terminal, debugging tools, and hosting features that support the creation and deployment of full-stack applications from a single workspace. Replitsupports multiple programming languages and provides preconfigured development environments so projects can start without installing local software.The platform includes collaboration features that enable multiple users to edit and run code within the same project in real time. It also offers AI-assisted coding tools that generate code suggestions, help debug programs, and assist with building applications through natural language prompts. Replit provides project sharing, templates, and integration with external services and repositories to support development workflows. |  | Seed | Mar 27, 2018 |  |
| Starcity | Starcity is a San Francisco-based owner and operator of Coliving communities. As of early 2020, Starcity has just under 500 beds in operation across San Francisco, Oakland, and Los Angeles, with a current committed development pipeline of approximately 2,000 units.Their 45-person team spans multiple disciplines including real estate, technology,design, and hospitality with employees from companies like Airbnb, CBRE, Cushman & Wakefield, Fairmont Hotels, FivePoint, Google, Tesla, Lyft, SoulCycle, The Standard, and Uber. They are urban housing enthusiasts on a mission to make great cities accessible to everyone.Starcity’s approach is different from other groups in the Coliving space. They are set up as both a General Partner and Operator with full-stack real estate development, design, and management capabilities. They love working on all aspects of design to maintain a keen focus on project details, and they enjoy having skin in the game when the opportunity presents itself. | $16.5M | Series A | Mar 06, 2018 |  |
| Bright Funds | Bright Funds is the next generation platform for individual and workplace giving, empowering everyday donors to become strategic philanthropists. Bright Funds supports thousands of individuals in their personal giving, and partners with the world's leading companies to bring impact-focused workplace giving to employees on a global scale.Bright Funds helps companies realize the true potential of a comprehensive corporate social responsibility strategy that takes into account the demands and expectations of a new generation of donors. |  | Seed | Dec 31, 2017 |  |
| NuCypher | NuCypher is a cryptography company that builds privacy-preserving infrastructure and protocols. It is an Ethereum token that can be staked to run a node on the NuCypher network. The company was founded in 2015 and is headquartered in San Francisco, California. | $4.4M |  | Dec 12, 2017 |  |
| Landed | Landed helps essential professionals (including those working in education and healthcare) buy homes and build financial security near the communities they serve through financial solutions, a network of trusted agents and lenders, and homebuying education and support. |  | Seed | Sep 15, 2017 |  |
| InsightRX | InsightRX is a software platform that incorporates the principles of quantitative pharmacology and machine learning to provide an individualized understanding of a patient’s response to treatment. It delivers its technology in the form of easy-to-use clinical decision support tools at the point-of-care to help guide treatment decision-making. Theplatform guides treatment decisions at both the individual level and the population level.InsightRX controls clinically validated pharmacokinetic models, patient physiology, pharmacogenomics, drug concentrations, and biomarkers to optimize dosing. It combines real-time patient data and machine learning to understand individual patient pharmacology and inform dose optimization. The platform also leverages disease-based pharmacodynamics models to inform treatment decision making.InsightRX was launched in 2015 by Ron Keizer, Sirj Goswami, and Ranvir Mangat. It is operated from San Francisco, California. | $2.8M | Seed | May 08, 2017 |  |

10 of 37 investments shown.

## Co-investors
- [Y Combinator](https://shizune.co/investors/profile/y-combinator) — VC Fund, 3 deals together
- [Amino Capital](https://shizune.co/investors/profile/zpark-venture) — VC Fund, 3 deals together
- [DCVC](https://shizune.co/investors/profile/data-collective) — VC Fund, 2 deals together
- [Fresh VC](https://shizune.co/investors/profile/fresh-vc) — VC Fund, 2 deals together
- [Rose Capital](https://shizune.co/investors/profile/rose-capital-0171) — VC Fund, 2 deals together
- [Soma Capital](https://shizune.co/investors/profile/soma-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Casa Verde Capital](https://shizune.co/investors/profile/casa-verde-capital) — VC Fund
- [Poseidon Asset Management](https://shizune.co/investors/profile/poseidon-assetmanagement) — VC Fund
- [Phyto Partners](https://shizune.co/investors/profile/phyto-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Chalmers Ventures AB](https://shizune.co/investors/profile/chalmers-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

## Featured in investor lists
- [Cannabis Investors in United States](https://shizune.co/investors/cannabis-investors-united-states)
- [Cannabis VC Funds](https://shizune.co/investors/cannabis-vc-funds)
- [Cannabis VC Funds in United States](https://shizune.co/investors/cannabis-vc-funds-united-states)
- [Film Investors in United States](https://shizune.co/investors/film-investors-united-states)
- [Food and Beverage VC Funds in Sweden](https://shizune.co/investors/food-and-beverage-vc-funds-sweden)
- [Organic Food VC Funds in Sweden](https://shizune.co/investors/organic-food-vc-funds-sweden)

## FAQ

### What does Mission and Market invest in?

Mission and Market invests primarily in Health Care, Biotechnology and Machine Learning startups, most often at Seed and Series A stage. Most of the 37 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Mission and Market's check size?

Mission and Market typically joins rounds of $1M–$5M at Seed and $10M–$17M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Mission and Market participates in.

### How do I contact Mission and Market?

Public channels for Mission and Market include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Mission and Market?

The team at Mission and Market includes Francesco Simoneschi (Co-Founder and Partner) and Simone Brunozzi (Founder, General Manager). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co